Skip to main content
logo
Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
50.03
-2.29 (-4.38%)
Sep 29, 2026, 1:24 PM EDT - Market open

Pulse Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.190.35--0.71.42
Revenue Growth
-----50.63%-
Cost of Revenue
1.180.54--11.941.97
Gross Profit
0-0.19---11.24-0.55
Selling, General & Admin
31.7632.0323.9215.7825.9733.82
Research & Development
51.8944.7232.3427.820.8428.64
Operating Expenses
83.6576.7556.2643.5746.8162.46
Operating Income
-83.64-76.94-56.26-43.57-58.06-63.01
Interest Expense
----1.1-0.9-0.7
Interest & Investment Income
3.024.212.692.460.640.05
Other Non Operating Income (Expenses)
-0.03-0.05-0.02---
EBT Excluding Unusual Items
-80.66-72.78-53.59-42.21-58.32-63.66
Gain (Loss) on Sale of Assets
-----0.19-
Pretax Income
-80.06-72.78-53.59-42.21-58.51-63.66
Net Income
-80.06-72.78-53.59-42.21-58.51-63.66
Net Income to Common
-80.06-72.78-53.59-42.21-58.51-63.66
Net Income Growth
------
Shares Outstanding (Basic)
686758503428
Shares Outstanding (Diluted)
686758503428
Shares Change
7.37%15.41%17.41%46.56%21.35%20.29%
EPS (Basic)
-1.18-1.08-0.92-0.85-1.72-2.28
EPS (Diluted)
-1.18-1.08-0.92-0.85-1.72-2.28
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-61.39-54.44-36.47-33.16-47.41-54.53
Free Cash Flow Per Share
-0.90-0.81-0.62-0.67-1.40-1.95
Gross Margin
0.25%-54.00%----38.79%
Operating Margin
-7058.40%-21982.57%---8293.86%-4443.87%
Profit Margin
-6755.78%-20794.57%---8357.86%-4489.42%
Free Cash Flow Margin
-5180.42%-15553.43%---6773.43%-3845.84%
EBITDA
-82.62-75.87-55.08-42.37-56.7-61.87
D&A For EBITDA
1.021.071.181.211.361.15
EBIT
-83.64-76.94-56.26-43.57-58.06-63.01
Revenue as Reported
----0.71.42
SEC Filings: 10-K · 10-Q